Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 26, 2017 10:00 ET | Source: Teligent, Inc.

Teligent, Inc. to Hold Conference Call for Third Quarter 2017 Results

BUENA, N.J., Oct. 26, 2017 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:30pm...
October 02, 2017 13:37 ET | Source: Teligent, Inc.

Teligent, Inc. Announces FDA Approval of Partnered ANDA for Desonide Lotion, 0.05%

BUENA, N.J., Oct. 02, 2017 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s...
September 19, 2017 08:00 ET | Source: Teligent, Inc.

Teligent, Inc. Announces FDA Approval of Triamcinolone Acetonide Cream USP, 0.1%

BUENA, N.J., Sept. 19, 2017 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s...
September 18, 2017 16:45 ET | Source: Teligent, Inc.

Teligent, Inc. Appoints Thomas J. Sabatino, Jr. to Board of Directors

BUENA, N.J., Sept. 18, 2017 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has appointed Thomas J. Sabatino, Jr. to...
September 12, 2017 08:00 ET | Source: Teligent, Inc.

Teligent, Inc. to Present at Morgan Stanley 15th Annual Global Healthcare Conference on September 12, 2017

BUENA, N.J., Sept. 12, 2017 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at the Morgan Stanley 15th Annual Global...
August 22, 2017 09:46 ET | Source: Teligent, Inc.

Teligent, Inc. Announces FDA Approval of Clobetasol Propionate Cream USP, 0.05%, Emollient

BUENA, N.J., Aug. 22, 2017 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s...
August 08, 2017 16:01 ET | Source: Teligent, Inc.

Teligent, Inc. Announces Second Quarter 2017 Results

BUENA, N.J., Aug. 08, 2017 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the second quarter...
July 28, 2017 08:00 ET | Source: Teligent, Inc.

Teligent, Inc. to Hold Conference Call for Second Quarter 2017 Results

BUENA, N.J., July 28, 2017 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:30pm...